Documents to download

Hepatitis is an inflammation of the liver. The most common forms of hepatitis are caused by hepatitis viruses, of which there are five main types. The World Health Organization (WHO) states that these are of greatest concern because of the “burden of illness and death they cause and the potential for outbreaks and epidemic spread”.  It cites types B and C as most concerning. These lead to chronic disease in hundreds of millions of people globally and, taken together, are the most common cause of liver cirrhosis and cancer. The WHO also believes the condition is being overlooked.

Viral hepatitis B and C affect 325 million people worldwide, leading to about 1.4 million deaths a year. It is the second major killer infectious disease after tuberculosis, and 9 times more people are infected with hepatitis than HIV. Deaths from hepatitis have been increasing over the past two decades, which points to a lack of global awareness and action, including among top decision-makers.

The need to combat hepatitis globally forms one of the targets under the sustainable development goals. These were agreed by UN member states, including the UK, in 2015. The WHO subsequently set the goal of eliminating viral hepatitis as a “major public health threat” by 2030 and reducing the mortality rate by 10% by 2020. The UK Government has stated it is committed to the goal of eliminating hepatitis C (the most common form of the virus in the UK) by 2030. 

World Hepatitis Day is held annually on 28 July and is promoted by the World Hepatitis Alliance. This year’s theme is ‘Invest in Eliminating Hepatitis’.

Documents to download

Related posts

  • Medicinal and agrochemical products can be granted a Supplementary Protection Certificate, an intellectual property right associated with patents, to provide up to five years of additional rights and protections once their patents have expired. In order to apply for an SPC, a product must receive approval to be sold on the UK market. Under the Northern Ireland/Ireland Protocol, products to be sold in Northern Ireland must obtain approval under EU law, whilst products to be sold in the rest of the UK will obtain approval under UK law. Currently, this marketing authorisation is only given on a UK-wide basis. This regulation amends the market authorisation process to enable authorisations to be granted for the Northern Ireland market only and for the Great Britain market only.

  • There is currently a system for mutual recognition of health and social care qualifications within and between European Economic Area states and Switzerland. The UK has passed legislation amending its provisions in this area to take account of its exit from the EU. In recent agreements with Switzerland and the European Free Trade Area states, the UK committed to conditions for these countries which go further than the legislation that has already been passed. The European Qualifications (Health and Social Care Professions) (EFTA States) (Amendment etc.) (EU Exit) Regulations 2020 would implement these commitments.

  • The UK will no longer be part of EU reciprocal and cross-border healthcare arrangements after the transition period ends on 31 December 2020. However, some groups of people will retain rights after this under the terms of the withdrawal agreement. The Government made regulations in 2019 to deal with reciprocal and cross-border healthcare if the UK left the EU with no ‘divorce’ deal. It is now planning to update these regulations to reflect the withdrawal agreement.